Guided Therapeutics (GTHP) Leases (2019 - 2025)
Guided Therapeutics (GTHP) has disclosed Leases for 7 consecutive years, with $686000.0 as the latest value for Q4 2025.
- Quarterly Leases rose 386.52% to $686000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $686000.0 through Dec 2025, up 386.52% year-over-year, with the annual reading at $686000.0 for FY2025, 386.52% up from the prior year.
- Leases hit $686000.0 in Q4 2025 for Guided Therapeutics, up from $69000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $686000.0 in Q4 2025 to a low of $69000.0 in Q3 2025.
- Historically, Leases has averaged $279750.0 across 5 years, with a median of $275500.0 in 2023.
- Biggest five-year swings in Leases: soared 536.07% in 2021 and later crashed 57.93% in 2025.
- Year by year, Leases stood at $372000.0 in 2021, then fell by 18.55% to $303000.0 in 2022, then dropped by 25.08% to $227000.0 in 2023, then crashed by 37.89% to $141000.0 in 2024, then skyrocketed by 386.52% to $686000.0 in 2025.
- Business Quant data shows Leases for GTHP at $686000.0 in Q4 2025, $69000.0 in Q3 2025, and $94000.0 in Q2 2025.